Stroke after thrombolysis: Mortality and functional outcomes in the GUSTO- I trial

Circulation

Volumn 92, Issue 10, 1995, Pages 2811-2818

  Gore, J M ^a   Granger, C B ^a   Simoons, M L ^a   Sloan, M A ^a   Weaver, W D ^a   White, H D ^a   Barbash, G I ^a   Van de Werf, F ^a   Aylward, P E ^a   Topol, E J ^a   Califf, R M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

mortality; stroke; thrombolysis; trials

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0028785426     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.10.2811     Document Type: Article

References (0)